Cargando…
Platelet Additive Solutions as an Alternative Storage Medium of Apheresis Platelets to Reduce ABO Antibody Titer for ABO-Incompatibility Platelet Transfusion
Introduction Platelet additive solutions (PASs) are nutrient media commonly used to replace and reduce the need for storage plasma. They are an alternative medium to maintain high-quality platelets lasting longer on the shelf for about seven days. Platelets with high titer of ABO antibody can pose a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517286/ https://www.ncbi.nlm.nih.gov/pubmed/37746385 http://dx.doi.org/10.7759/cureus.44012 |
_version_ | 1785109291146936320 |
---|---|
author | Adzahar, Sumaiyah Hassan, Mohd Nazri Zulkafli, Zefarina Mohd Noor, Noor Haslina Ramli, Marini Mohamed Yusoff, Shafini Lam, Sien Tzi Deshpande, Rajesh Abdullah, Wan Zaidah |
author_facet | Adzahar, Sumaiyah Hassan, Mohd Nazri Zulkafli, Zefarina Mohd Noor, Noor Haslina Ramli, Marini Mohamed Yusoff, Shafini Lam, Sien Tzi Deshpande, Rajesh Abdullah, Wan Zaidah |
author_sort | Adzahar, Sumaiyah |
collection | PubMed |
description | Introduction Platelet additive solutions (PASs) are nutrient media commonly used to replace and reduce the need for storage plasma. They are an alternative medium to maintain high-quality platelets lasting longer on the shelf for about seven days. Platelets with high titer of ABO antibody can pose a hemolytic transfusion reaction (HTR) risk if units are given across the ABO barrier. The risk of complication is greater when group O platelet is released to non-group O patients. The PAS has been known as a safe medium, where the titer of ABO antibodies is expected to be diluted. In this study, we compared the anti-A and anti-B antibody titers of apheresis platelets in PAS and non-PAS (plasma) as the suspending media. Methods A total of 20 apheresis platelet donors were selected, with seven from blood group A, eight from blood group B, and five from blood group O. The platelets were collected using an Amicus cell separator. They were suspended in PAS and plasma before being stored at a temperature range of 22-24(º )C. Anti-A (blood group B and O) and Anti-B (blood group A and O) antibody titers were measured and compared between the two suspending media. Wilcoxon signed-rank test is used for statistical analysis, and a p-value <0.05 is considered significant. Results The median titer of the anti-A antibody of apheresis platelets showed a significant difference between suspended in PAS (2.50) and plasma (4.00), p=0.002. Similar findings were also seen with the median titer of the anti-B antibody of apheresis platelet, in which it showed a significant difference between suspended in PAS (2.00) and plasma (4.00), p=0.004. It was observed that there was a significant reduction in both anti-A and anti-B antibody titers in the PAS as compared to the plasma group. Conclusion The decrease in ABO antibody titer in apheresis platelets stored with PAS can be beneficial for patients. This reduces the risk of HTRs if ABO-incompatible platelet units need to be issued. Thus, using PAS as a storage medium significantly improves platelet inventory management without compromising patient safety. |
format | Online Article Text |
id | pubmed-10517286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-105172862023-09-24 Platelet Additive Solutions as an Alternative Storage Medium of Apheresis Platelets to Reduce ABO Antibody Titer for ABO-Incompatibility Platelet Transfusion Adzahar, Sumaiyah Hassan, Mohd Nazri Zulkafli, Zefarina Mohd Noor, Noor Haslina Ramli, Marini Mohamed Yusoff, Shafini Lam, Sien Tzi Deshpande, Rajesh Abdullah, Wan Zaidah Cureus Hematology Introduction Platelet additive solutions (PASs) are nutrient media commonly used to replace and reduce the need for storage plasma. They are an alternative medium to maintain high-quality platelets lasting longer on the shelf for about seven days. Platelets with high titer of ABO antibody can pose a hemolytic transfusion reaction (HTR) risk if units are given across the ABO barrier. The risk of complication is greater when group O platelet is released to non-group O patients. The PAS has been known as a safe medium, where the titer of ABO antibodies is expected to be diluted. In this study, we compared the anti-A and anti-B antibody titers of apheresis platelets in PAS and non-PAS (plasma) as the suspending media. Methods A total of 20 apheresis platelet donors were selected, with seven from blood group A, eight from blood group B, and five from blood group O. The platelets were collected using an Amicus cell separator. They were suspended in PAS and plasma before being stored at a temperature range of 22-24(º )C. Anti-A (blood group B and O) and Anti-B (blood group A and O) antibody titers were measured and compared between the two suspending media. Wilcoxon signed-rank test is used for statistical analysis, and a p-value <0.05 is considered significant. Results The median titer of the anti-A antibody of apheresis platelets showed a significant difference between suspended in PAS (2.50) and plasma (4.00), p=0.002. Similar findings were also seen with the median titer of the anti-B antibody of apheresis platelet, in which it showed a significant difference between suspended in PAS (2.00) and plasma (4.00), p=0.004. It was observed that there was a significant reduction in both anti-A and anti-B antibody titers in the PAS as compared to the plasma group. Conclusion The decrease in ABO antibody titer in apheresis platelets stored with PAS can be beneficial for patients. This reduces the risk of HTRs if ABO-incompatible platelet units need to be issued. Thus, using PAS as a storage medium significantly improves platelet inventory management without compromising patient safety. Cureus 2023-08-23 /pmc/articles/PMC10517286/ /pubmed/37746385 http://dx.doi.org/10.7759/cureus.44012 Text en Copyright © 2023, Adzahar et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Hematology Adzahar, Sumaiyah Hassan, Mohd Nazri Zulkafli, Zefarina Mohd Noor, Noor Haslina Ramli, Marini Mohamed Yusoff, Shafini Lam, Sien Tzi Deshpande, Rajesh Abdullah, Wan Zaidah Platelet Additive Solutions as an Alternative Storage Medium of Apheresis Platelets to Reduce ABO Antibody Titer for ABO-Incompatibility Platelet Transfusion |
title | Platelet Additive Solutions as an Alternative Storage Medium of Apheresis Platelets to Reduce ABO Antibody Titer for ABO-Incompatibility Platelet Transfusion |
title_full | Platelet Additive Solutions as an Alternative Storage Medium of Apheresis Platelets to Reduce ABO Antibody Titer for ABO-Incompatibility Platelet Transfusion |
title_fullStr | Platelet Additive Solutions as an Alternative Storage Medium of Apheresis Platelets to Reduce ABO Antibody Titer for ABO-Incompatibility Platelet Transfusion |
title_full_unstemmed | Platelet Additive Solutions as an Alternative Storage Medium of Apheresis Platelets to Reduce ABO Antibody Titer for ABO-Incompatibility Platelet Transfusion |
title_short | Platelet Additive Solutions as an Alternative Storage Medium of Apheresis Platelets to Reduce ABO Antibody Titer for ABO-Incompatibility Platelet Transfusion |
title_sort | platelet additive solutions as an alternative storage medium of apheresis platelets to reduce abo antibody titer for abo-incompatibility platelet transfusion |
topic | Hematology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517286/ https://www.ncbi.nlm.nih.gov/pubmed/37746385 http://dx.doi.org/10.7759/cureus.44012 |
work_keys_str_mv | AT adzaharsumaiyah plateletadditivesolutionsasanalternativestoragemediumofapheresisplateletstoreduceaboantibodytiterforaboincompatibilityplatelettransfusion AT hassanmohdnazri plateletadditivesolutionsasanalternativestoragemediumofapheresisplateletstoreduceaboantibodytiterforaboincompatibilityplatelettransfusion AT zulkaflizefarina plateletadditivesolutionsasanalternativestoragemediumofapheresisplateletstoreduceaboantibodytiterforaboincompatibilityplatelettransfusion AT mohdnoornoorhaslina plateletadditivesolutionsasanalternativestoragemediumofapheresisplateletstoreduceaboantibodytiterforaboincompatibilityplatelettransfusion AT ramlimarini plateletadditivesolutionsasanalternativestoragemediumofapheresisplateletstoreduceaboantibodytiterforaboincompatibilityplatelettransfusion AT mohamedyusoffshafini plateletadditivesolutionsasanalternativestoragemediumofapheresisplateletstoreduceaboantibodytiterforaboincompatibilityplatelettransfusion AT lamsientzi plateletadditivesolutionsasanalternativestoragemediumofapheresisplateletstoreduceaboantibodytiterforaboincompatibilityplatelettransfusion AT deshpanderajesh plateletadditivesolutionsasanalternativestoragemediumofapheresisplateletstoreduceaboantibodytiterforaboincompatibilityplatelettransfusion AT abdullahwanzaidah plateletadditivesolutionsasanalternativestoragemediumofapheresisplateletstoreduceaboantibodytiterforaboincompatibilityplatelettransfusion |